8FD1 image
Deposition Date 2022-12-01
Release Date 2023-08-30
Last Version Date 2024-10-23
Entry Detail
PDB ID:
8FD1
Title:
Crystal structure of photoactivated rhodopsin in complex with a nanobody
Biological Source:
Source Organism:
Lama glama (Taxon ID: 9844)
Bos taurus (Taxon ID: 9913)
Host Organism:
Method Details:
Experimental Method:
Resolution:
4.25 Å
R-Value Free:
0.29
R-Value Work:
0.27
R-Value Observed:
0.28
Space Group:
P 31 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Rhodopsin
Gene (Uniprot):RHO
Chain IDs:A, B
Chain Length:348
Number of Molecules:2
Biological Source:Bos taurus
Polymer Type:polypeptide(L)
Molecule:Nanobody Nb2
Chain IDs:C, D
Chain Length:126
Number of Molecules:2
Biological Source:Lama glama
Ligand Molecules
Primary Citation
Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain.
Nat Commun 14 5209 5209 (2023)
PMID: 37626045 DOI: 10.1038/s41467-023-40911-9

Abstact

Rhodopsin is a prototypical G protein-coupled receptor (GPCR) critical for vertebrate vision. Research on GPCR signaling states has been facilitated using llama-derived nanobodies (Nbs), some of which bind to the intracellular surface to allosterically modulate the receptor. Extracellularly binding allosteric nanobodies have also been investigated, but the structural basis for their activity has not been resolved to date. Here, we report a library of Nbs that bind to the extracellular surface of rhodopsin and allosterically modulate the thermodynamics of its activation process. Crystal structures of Nb2 in complex with native rhodopsin reveal a mechanism of allosteric modulation involving extracellular loop 2 and native glycans. Nb2 binding suppresses Schiff base deprotonation and hydrolysis and prevents intracellular outward movement of helices five and six - a universal activation event for GPCRs. Nb2 also mitigates protein misfolding in a disease-associated mutant rhodopsin. Our data show the power of nanobodies to modulate the photoactivation of rhodopsin and potentially serve as therapeutic agents for disease-associated rhodopsin misfolding.

Legend

Protein

Chemical

Disease

Primary Citation of related structures